Key Takeaways

• Differential pressure acts as a critical containment barrier in pharmaceutical cleanrooms by preventing the escape of hazardous airborne particles.

• Maintaining a consistent pressure difference between zones ensures that airflow moves strictly from cleaner areas to surrounding buffer spaces.

• Continuous tracking via an independent environmental monitoring system is essential to safeguard facility integrity and quickly flag airflow anomalies.

• Compliance with Australian TGA regulations requires therapeutic goods manufacturers to retain robust, tamper-proof environmental records for seven years.

The Role of Differential Pressure in Biosecurity

In the pharmaceutical and life sciences sector, managing the risk of working with potentially hazardous bio products is essential. Research and processing facilities use a range of techniques to ensure that hazardous items remain in a strictly controlled, cleanroom environment – including filtering, isolation, HVAC, and differential pressure.

In this article, we take a look specifically at differential pressure as a biosecurity mechanism – its role in hazard management, the need to comply with industry standards and regulations, and best practices for maintaining – and proving that you have maintained – a secure environment.

How differential pressure prevents contamination

For organisations working with bio products, differential pressure is one of the primary ways of ensuring that hazardous materials (for example, the COVID-19 virus) cannot escape into the wider surroundings. Different areas within the facility have different levels of air pressure, ensuring the correct airflow direction to prevent contamination. Particles cannot move from an area with lower pressure into a neighbouring area that has higher pressure.

The difference in pressure between rooms can be as low as 30-50 Pascals, rendering it virtually undetectable by humans. Yet this minimal difference is sufficient to contain hazardous materials. Researchers or scientists enter the facility at atmospheric pressure and pass through airlocks as they move from one pressure zone to the next.

The importance of continuous monitoring

For organisations using differential pressure to maintain optimal cleanroom conditions, monitoring pressure differences is essential. They must consistently measure the pressure differences between cleanrooms and in the buffer zones between the cleanroom and uncontrolled areas—such as airlocks or transfer chambers. These buffer zones protect against contamination of the cleanroom environment when materials or people enter.

A failure of the pressure differential could mean that a hazardous substance leaks into the next room, or out of the building entirely, causing significant potential danger and damage.

Regulatory compliance and industry standards

Australia: TGA regulations and GMP requirements

Industries that work with bio materials are highly regulated, and organisations must comply with strict guidelines. In Australia, the Therapeutic Goods Administration (TGA) issues licences for the production of therapeutic goods, including pharmaceuticals and medical devices. All facilities must comply with TGA regulations to gain and retain their licence.

The TGA mandates regular testing of air, surfaces, and personnel within manufacturing facilities, including monitoring of temperature, humidity, pressure, and airflow in critical areas to maintain appropriate conditions for production. They also impose rules about sampling frequency and data analysis to identify trends and anomalies.

The TGA also regulates Good Manufacturing Practice (GMP) for therapeutic goods. Of particular relevance to differential pressure monitoring are:

• GMP 5 (Premises): Ensures that manufacturing facilities are designed and maintained to prevent contamination.
• GMP 6 (Procedures): Sets standards for documentation and record-keeping to track production activities.

To meet TGA standards, organisations must monitor their environments and retain all captured data for seven years.

International compliance: FDA, ISO, and other standards

For organisations that export their products overseas, compliance with the importing country’s regulations is also essential. In the US, this means adhering to the regulations of the Food and Drug Administration (FDA) and complying with 21 CFR Part 11, which governs electronic records used in GMP.

Organisations with ISO certification—such as ISO 14644 for Cleanrooms—must also meet the appropriate ISO standards to retain their certification.

Best practice for monitoring and compliance

The best-practice approach to monitoring differential pressure and other environmental conditions consists of three parts: Monitor, Alert, Audit.

Monitor: Capturing real-time data

The first step is to have the appropriate equipment to ensure accurate, real-time, consistent monitoring of pressure differences between work areas.

• Sensors: Specialist differential pressure sensors measure the pressure of a room relative to the atmosphere or adjacent rooms. To prevent potentially contaminated air from entering the cleanroom, it must maintain a higher pressure than surrounding areas. More important than the absolute pressure of any given room is the differential between that room and its neighbours.
• Environmental monitoring systems (EMS): Alongside sensors, best practice includes having an EMS that captures and interprets data. Most EMS platforms have a base system with add-on functionality tailored to specific functions, such as life sciences compliance.

Many organisations implement redundancy by splitting the EMS system into two or three parts, with each section monitoring different facility areas.

Another best practice is keeping the monitoring system independent of the HVAC system. In fact, it is common to have a primary and secondary EMS for the highest level of data integrity. This independence ensures that monitoring data remains accurate, even if HVAC systems malfunction or fluctuate.

Alert: Responding to anomalies

The EMS continuously monitors pressure levels and logs data. It is pre-programmed with acceptable tolerances, and if pressure deviates from the defined range, an automatic alert is sent to the designated team—typically the engineering team—to investigate and take corrective action.

Audit: Maintaining records for compliance

Monitoring is not just about real-time data; it also involves maintaining a robust audit trail to ensure regulatory compliance.

• The EMS system must capture historical data with appropriate data retention standards aligned with GMP practices.
• A comprehensive hierarchy of authorities and permissions should be in place to control access to critical data and system changes.
• The EMS should allow organisations to trace every step of production in case of an investigation—such as drug failure or contamination.
• Under GMP, manufacturers must demonstrate that any changes to monitoring thresholds were made by authorised personnel with appropriate authorisation levels.
• Organisations must also track calibration checks on sensors and monitoring equipment to ensure accurate readings.

An EMS typically holds a high percentage of the evidence needed for compliance audits and regulatory reviews, making it a vital part of any pharmaceutical or life sciences facility.

In summary, differential pressure is a vital part of maintaining bio security, but in order to be fully effective, it must also follow best practice, using monitoring, alerts and audit in order to meet the most stringent regulatory standards.

Frequently Asked Questions